Group 1 - The Supervisory Board of Ananda Drive Technology (Shanghai) Co., Ltd. held its ninth meeting of the fourth session on August 28, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [1][2]. - The Supervisory Board approved the 2025 semi-annual report and its summary, confirming that the report's preparation and review process adhered to legal and regulatory requirements, and the disclosed information accurately reflects the company's financial status and operational results [1][2]. - The Supervisory Board also approved the special report on the storage and actual use of raised funds for the first half of 2025, with unanimous support from all supervisors [2][3]. Group 2 - The profit distribution plan for the first half of 2025 was approved by the Supervisory Board, considering the company's operational situation and future funding needs, ensuring it does not harm the interests of the company or shareholders, particularly minority shareholders [2][3].

Core Viewpoint - The board of directors of Aili Home Technology Co., Ltd. held its 14th meeting of the third session, where they unanimously approved the 2025 semi-annual report and its summary, reflecting the company's financial status and operational results accurately [1][2]. Group 1: Board Meeting Details - The board meeting was held on August 27, 2025, with all 9 directors present, meeting the legal requirements for a valid resolution [1]. - The meeting was chaired by Chairman Song Zhengxing and conducted both in-person and via communication methods [1]. Group 2: Resolutions Passed - The board approved the proposal regarding the 2025 semi-annual report and its summary, which was deemed to fairly reflect the company's financial condition and operational results during the reporting period [1][2]. - The board also approved the special report on the storage and usage of raised funds for the first half of 2025, confirming that it adequately reflects the situation [2].

Core Points - The company held the seventh meeting of the eighth supervisory board on August 26, 2025, where several key resolutions were passed [1] - The supervisory board approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's actual situation [1] - A proposal to amend the company's articles of association and to abolish the supervisory board was approved, with the audit committee set to assume the supervisory functions [2] - The board also approved a special report on the use of raised funds for the first half of 2025 [3] - A mid-year profit distribution plan for 2025 was approved, pending shareholder meeting approval [3] - A risk assessment report regarding the company's financial subsidiary was passed, with some supervisors abstaining from the vote due to conflicts of interest [3][4] - A proposal for credit limit application and related transactions with the financial subsidiary was also approved, subject to shareholder meeting review [3][4]

Group 1 - The board of directors of Demar Technology Group Co., Ltd. held its 25th meeting on August 25, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1] - The board approved the 2025 semi-annual report and its summary, confirming that the report's preparation and review procedures were legal and compliant with regulations [2] - The board also approved a special report on the use of raised funds for the first half of 2025, with all votes in favor [2] Group 2 - The board approved a proposal to amend the company's articles of association, which will require further approval from the shareholders' meeting [3] - A resolution was passed to invalidate a portion of the restricted stock incentive plan from 2022, as the performance targets for 2024 were not met, resulting in the cancellation of 685,000 shares [3][4] - The board approved a proposal to convene the first temporary shareholders' meeting of 2025, with unanimous support from the directors [5]

Group 1 - The company held its 11th meeting of the 3rd Supervisory Board on August 25, 2025, with all 3 supervisors present, ensuring compliance with legal and regulatory requirements [1][2] - The Supervisory Board approved the 2025 Half-Year Report, confirming that the report's preparation and review processes adhered to relevant laws and internal regulations, and accurately reflected the company's financial status and operational results [1][2] - The Supervisory Board also approved the Special Report on the Storage and Actual Use of Raised Funds for the first half of 2025, confirming that the funds were stored in dedicated accounts and used appropriately without any violations [2]

Core Points - The company, Chengbang Ecological Environment Co., Ltd., is announcing a stock issuance to specific targets for the year 2025 without the need to prepare a report on the use of previously raised funds [1] - The company has not raised funds through methods such as private placements, rights issues, or convertible bonds in the last five accounting years [1] - The last time the company raised funds was in 2017, which exceeds the five-year period required for reporting on the use of those funds [1] Summary by Sections - The company’s board of directors guarantees the announcement's content is free from false records, misleading statements, or significant omissions, and they bear responsibility for its authenticity, accuracy, and completeness [2] - According to the regulations from the China Securities Regulatory Commission, a report on the use of previously raised funds is not required if the funds were raised more than five accounting years ago [1] - The company is not required to hire an accounting firm to provide verification reports on the use of previous funds due to the elapsed time since the last fundraising [1]

Core Viewpoint - The board of directors of Beijing Tiantan Biological Products Co., Ltd. has approved several key resolutions during its 24th meeting, including the approval of the 2025 semi-annual report and profit distribution plan, as well as the establishment of a new plasma collection station project [1][2][3]. Group 1: Financial Reports and Profit Distribution - The board approved the 2025 semi-annual report and its summary with a unanimous vote of 9 in favor [1]. - The profit distribution plan for the first half of 2025 was approved, with a total distribution amount of 296,605,716.90 yuan (including tax), with no stock dividends or capital reserve transfers [1][2]. Group 2: Fund Management and Risk Assessment - The board approved the special report on the storage and actual use of raised funds for the first half of 2025, with a unanimous vote of 9 in favor [2]. - A risk assessment report regarding China National Pharmaceutical Group Financial Co., Ltd. was approved, indicating no significant deficiencies in risk management and that the financial services provided were fair and reasonable [2][3]. Group 3: Corporate Governance and New Projects - The board approved the rules for the general manager's office meetings with a unanimous vote of 9 in favor [3]. - The board agreed to the investment in the construction of a new plasma collection station by Chengdu Rongsheng Pharmaceutical Co., Ltd., with the project receiving prior approval from the strategic and investment committee [3]. - The company agreed to donate 400,000 yuan to the Gansu Red Cross for emergency disaster relief and post-disaster reconstruction efforts [3].